Equities

Haemonetics Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Haemonetics Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)57.01
  • Today's Change-0.49 / -0.85%
  • Shares traded209.17k
  • 1 Year change-7.01%
  • Beta0.2803
Data delayed at least 15 minutes, as of Feb 12 2026 16:04 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.

  • Revenue in USD (TTM)1.32bn
  • Net income in USD175.44m
  • Incorporated1985
  • Employees3.02k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HAE:NYQ since
announced
Transaction
value
Vivasure Medical LtdDeal completed09 Jan 202609 Jan 2026Deal completed-32.16%--
Data delayed at least 15 minutes, as of Feb 12 2026 16:04 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AxoGen Inc214.71m-2.10m1.70bn451.00--12.94350.167.91-0.0486-0.04864.562.621.051.557.75476,073.20-1.03-11.36-1.17-13.0574.7678.42-0.9767-15.372.640.64930.2852--17.8111.9154.12---2.84--
Pulse Biosciences Inc86.00k-74.73m1.71bn75.00--18.45--19,896.88-1.14-1.140.00131.370.0009----1,146.67-74.06-83.75-80.63-94.40-224.42---86,898.84-12,644.5210.01--0.00-------26.95---27.12--
Artivion Inc422.65m-9.12m1.90bn1.60k--4.33137.124.49-0.242-0.2429.489.260.5091.725.16264,153.80-1.10-2.47-1.29-2.6664.5065.02-2.16-5.892.881.290.3324--9.757.0656.37--6.75--
Quidelortho Corp2.71bn-1.18bn1.96bn6.60k--0.9603--0.7208-17.38-17.3840.1129.990.43512.417.18411,272.70-18.910.0044-22.090.00547.1559.13-43.450.0090.98050.65370.56630.00-7.1739.07-20,216.83--48.27--
Inspire Medical Systems Inc911.98m56.67m1.98bn1.25k35.292.5028.052.171.934.9730.7527.331.061.188.57--6.610.07167.400.080685.3984.836.210.07064.56------13.6051.215.91------
LeMaitre Vascular Inc240.87m53.34m1.99bn651.0038.475.2531.308.272.282.2810.3516.710.4941.037.45369,993.8010.949.0911.699.8970.9766.2422.1416.6411.45--0.307738.3813.6313.4046.2819.6813.1115.91
Alphatec Holdings Inc728.02m-154.96m2.00bn867.00--174.84--2.75-1.05-1.054.910.23510.94971.287.90839,700.10-20.21-27.43-26.81-34.6969.2366.99-21.29-39.401.24-1.860.941--26.8140.0713.14--48.19--
UFP Technologies Inc597.95m67.12m2.03bn4.15k30.595.0323.653.408.618.6176.7152.370.92614.896.86144,223.8010.4010.1211.8711.5328.5127.0711.2310.641.368.390.26570.0026.0820.5231.2924.4610.82--
Establishment Labs Holdings Inc190.97m-82.98m2.11bn1.02k--129.13--11.06-2.84-2.846.530.56320.61450.7692.75187,596.30-26.70-31.53-33.25-39.3268.7465.46-43.45-45.092.10-1.720.9377--0.529213.14-7.76--17.33--
Heartflow Inc-100.00bn-100.00bn2.30bn699.00--8.84----------3.05----------------------------0.00--44.32--22.04------
Neogen Corp880.32m-602.74m2.34bn2.97k--1.11--2.66-2.78-2.784.059.670.23752.635.95296,005.00-16.26-7.73-16.94-8.0645.9848.10-68.47-27.912.80-0.21090.2737---3.2016.43-11,491.59--34.18--
10X Genomics Inc641.81m-76.32m2.42bn1.31k--3.09--3.78-0.6249-0.62495.196.200.65322.5610.08491,434.90-7.77-25.61-9.00-29.1968.9074.03-11.89-47.524.06--0.00---1.2819.9628.41---20.72--
Haemonetics Corp1.32bn175.44m2.67bn3.02k15.802.959.282.033.643.6427.4019.460.5251.586.47436,081.706.995.418.306.5559.3253.2013.319.181.1512.450.57330.003.956.6042.6416.994.37--
DENTSPLY SIRONA Inc3.62bn-882.00m2.74bn14.00k--1.85--0.7549-4.43-4.4318.187.410.59032.725.47258,857.10-14.35-4.06-18.88-4.8351.1053.14-24.31-8.590.98659.680.6184---4.34-1.17-589.39--7.9111.28
Integer Holdings Corp1.83bn87.20m3.05bn11.00k36.371.7514.461.672.402.3951.7649.830.55785.044.83166,461.302.663.282.843.5427.1526.704.766.382.455.230.41120.0010.356.4135.805.8216.99--
LivaNova PLC1.35bn-217.49m3.63bn2.90k--3.13--2.69-4.01-4.0124.6421.190.53112.586.60465,159.30-8.56-4.14-11.07-5.0368.5067.61-16.12-9.041.1210.220.273--8.662.94260.39--10.98--
Data as of Feb 12 2026. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD

Institutional shareholders

49.36%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20255.30m11.33%
The Vanguard Group, Inc.as of 31 Dec 20254.37m9.33%
Neuberger Berman Investment Advisers LLCas of 30 Sep 20253.67m7.84%
AQR Capital Management LLCas of 30 Sep 20252.13m4.55%
SSgA Funds Management, Inc.as of 30 Sep 20251.80m3.85%
River Road Asset Management LLCas of 30 Sep 20251.65m3.54%
Geode Capital Management LLCas of 30 Sep 20251.20m2.57%
Dimensional Fund Advisors LPas of 30 Sep 20251.03m2.20%
T. Rowe Price Investment Management, Inc.as of 30 Sep 20251.01m2.16%
Allspring Global Investments LLCas of 31 Dec 2025938.88k2.01%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.